help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, T. A.
Right arrow Articles by Bradford, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, T. A.
Right arrow Articles by Bradford, A. P.
Molecular Endocrinology 15 (9): 1517-1528
Copyright © 2001 by The Endocrine Society

Fibroblast Growth Factor Activation of the Rat PRL Promoter is Mediated by PKC{delta}

Twila A. Jackson, Rebecca E. Schweppe, David M. Koterwas and Andrew P. Bradford

Department of Obstetrics and Gynecology (T.A.J., D.M.K., A.P.B.), Department of Biochemistry and Molecular Genetics (R.E.S., A.P.B.), and the Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, Colorado 80262

Fibroblast growth factors play a critical role in cell growth, development, and differentiation and are also implicated in the formation and progression of tumors in a variety of tissues including pituitary. We have previously shown that fibroblast growth factor activation of the rat PRL promoter in GH4T2 pituitary tumor cells is mediated via MAP kinase in a Ras/Raf-1-independent manner. Herein we show using biochemical, molecular, and pharmacological approaches that PKC{delta} is a critical component of the fibroblast growth factor signaling pathway. PKC inhibitors, or down-regulation of PKC, rendered the rat PRL promoter refractory to subsequent stimulation by fibroblast growth factors, implying a role for PKC in fibroblast growth factor signal transduction. FGFs caused specific translocation of PKC{delta} from cytosolic to membrane fractions, consistent with enzyme activation. In contrast, other PKCs expressed in GH4T2 cells ({alpha}, ßI, ßII, and {epsilon}) did not translocate in response to fibroblast growth factors. The PKC{delta} subtype-selective inhibitor, rottlerin, or expression of a dominant negative PKC{delta} adenoviral construct also blocked fibroblast growth factor induction of rat PRL promoter activity, confirming a role for the novel PKC{delta} isoform. PKC inhibitors selective for the conventional {alpha} and ß isoforms or dominant negative PKC{alpha} adenoviral expression constructs had no effect. Induction of the endogenous PRL gene was also blocked by adenoviral dominant negative PKC{delta} expression but not by an analogous dominant negative PKC{alpha} construct. Finally, rottlerin significantly attenuated FGF-induced MAP kinase phosphorylation. Together, these results indicate that MAP kinase-dependent fibroblast growth factor stimulation of the rat PRL promoter in pituitary cells is mediated by PKC{delta}.




This article has been cited by other articles:


Home page
 Endocr Relat CancerHome page
J. M Haughian, T. A Jackson, D. M Koterwas, and A. P Bradford
Endometrial cancer cell survival and apoptosis is regulated by protein kinase C {alpha} and {delta}
Endocr. Relat. Cancer, December 1, 2006; 13(4): 1251 - 1267.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
M. Gartsbein, A. Alt, K. Hashimoto, K. Nakajima, T. Kuroki, and T. Tennenbaum
The role of protein kinase C {delta} activation and STAT3 Ser727 phosphorylation in insulin-induced keratinocyte proliferation
J. Cell Sci., February 1, 2006; 119(3): 470 - 481.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Shao, L. Qiao, R. C. Janssen, M. Pagliassotti, and J. E. Friedman
Chronic Hyperglycemia Enhances PEPCK Gene Expression and Hepatocellular Glucose Production Via Elevated Liver Activating Protein/Liver Inhibitory Protein Ratio
Diabetes, April 1, 2005; 54(4): 976 - 984.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Chaturvedi and D. K. Sarkar
Mediation of Basic Fibroblast Growth Factor-Induced Lactotropic Cell Proliferation by Src-Ras-Mitogen-Activated Protein Kinase p44/42 Signaling
Endocrinology, April 1, 2005; 146(4): 1948 - 1955.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
D. N. JACKSON and D. A. FOSTER
The enigmatic protein kinase C{delta}: complex roles in cell proliferation and survival
FASEB J, April 1, 2004; 18(6): 627 - 636.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T. A. Jackson, D. M. Koterwas, M. A. Morgan, and A. P. Bradford
Fibroblast Growth Factors Regulate Prolactin Transcription via an Atypical Rac-Dependent Signaling Pathway
Mol. Endocrinol., October 1, 2003; 17(10): 1921 - 1930.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H.-J. Kim, J.-H. Kim, S.-C. Bae, J.-Y. Choi, H.-J. Kim, and H.-M. Ryoo
The Protein Kinase C Pathway Plays a Central Role in the Fibroblast Growth Factor-stimulated Expression and Transactivation Activity of Runx2
J. Biol. Chem., January 3, 2003; 278(1): 319 - 326.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. A. Pickett, N. Manning, Y. Akita, and A. Gutierrez-Hartmann
Role of Specific Protein Kinase C Isozymes in Mediating Epidermal Growth Factor, Thyrotropin-Releasing Hormone, and Phorbol Ester Regulation of the Rat Prolactin Promoter in GH4/GH4C1 Pituitary Cells
Mol. Endocrinol., December 1, 2002; 16(12): 2840 - 2852.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society